FI60006C - Foerfarande foer framstaellning av farmakologiskt vaerdefulla n-(1-(3,4-metylendioxifenyl)propyl(2))-n'-(substituerad fenyl)piperaziner och deras syraadditionssalter - Google Patents
Foerfarande foer framstaellning av farmakologiskt vaerdefulla n-(1-(3,4-metylendioxifenyl)propyl(2))-n'-(substituerad fenyl)piperaziner och deras syraadditionssalter Download PDFInfo
- Publication number
- FI60006C FI60006C FI752288A FI752288A FI60006C FI 60006 C FI60006 C FI 60006C FI 752288 A FI752288 A FI 752288A FI 752288 A FI752288 A FI 752288A FI 60006 C FI60006 C FI 60006C
- Authority
- FI
- Finland
- Prior art keywords
- methylenedioxyphenyl
- general formula
- propyl
- piperazine
- substituted phenyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 16
- 230000000144 pharmacologic effect Effects 0.000 title description 3
- OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical class [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 title 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 title 1
- -1 (4-methylenedioxyphenyl) propyl Chemical group 0.000 claims description 31
- 150000001875 compounds Chemical class 0.000 claims description 27
- XIYKRJLTYKUWAM-UHFFFAOYSA-N 3,4-methylenedioxyphenylpropan-2-one Chemical compound CC(=O)CC1=CC=C2OCOC2=C1 XIYKRJLTYKUWAM-UHFFFAOYSA-N 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 239000000460 chlorine Substances 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 6
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- 150000002431 hydrogen Chemical class 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 3
- 229910052987 metal hydride Inorganic materials 0.000 claims description 3
- 150000004681 metal hydrides Chemical class 0.000 claims description 3
- 239000001294 propane Substances 0.000 claims description 3
- 239000012279 sodium borohydride Substances 0.000 claims description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 2
- 239000003638 chemical reducing agent Substances 0.000 claims description 2
- 125000004427 diamine group Chemical group 0.000 claims description 2
- 125000001495 ethyl group Chemical class [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 239000002516 radical scavenger Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims 1
- 125000000129 anionic group Chemical group 0.000 claims 1
- 150000001649 bromium compounds Chemical class 0.000 claims 1
- 230000003197 catalytic effect Effects 0.000 claims 1
- 150000001768 cations Chemical class 0.000 claims 1
- 150000004985 diamines Chemical class 0.000 claims 1
- 238000005984 hydrogenation reaction Methods 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000005490 tosylate group Chemical group 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 238000002474 experimental method Methods 0.000 description 7
- 238000010171 animal model Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- 229960001214 clofibrate Drugs 0.000 description 4
- 229940072033 potash Drugs 0.000 description 4
- 235000015320 potassium carbonate Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- PXFYAFDHWSXVLU-UHFFFAOYSA-N 1-(3,4-Methylenedioxyphenyl)-propane-1-ol Chemical compound CCC(O)C1=CC=C2OCOC2=C1 PXFYAFDHWSXVLU-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000003874 central nervous system depressant Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000003218 coronary vasodilator agent Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- YSJHCQGGIPTMQM-UHFFFAOYSA-N 1-(2,4-dichlorophenyl)piperazine Chemical compound ClC1=CC(Cl)=CC=C1N1CCNCC1 YSJHCQGGIPTMQM-UHFFFAOYSA-N 0.000 description 1
- QACLELNFVSMAIZ-UHFFFAOYSA-N 1-(4-methoxy-2-methylphenyl)piperazine Chemical compound CC1=CC(OC)=CC=C1N1CCNCC1 QACLELNFVSMAIZ-UHFFFAOYSA-N 0.000 description 1
- KQCMTOWTPBNWDB-UHFFFAOYSA-N 2,4-dichloroaniline Chemical compound NC1=CC=C(Cl)C=C1Cl KQCMTOWTPBNWDB-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- YMLDPUKTWZCCTM-UHFFFAOYSA-N C1(=CC=CC=C1)N1C(C(N(CC1)C(C)(C)C1=CC2=C(C=C1)OCO2)=O)=O Chemical compound C1(=CC=CC=C1)N1C(C(N(CC1)C(C)(C)C1=CC2=C(C=C1)OCO2)=O)=O YMLDPUKTWZCCTM-UHFFFAOYSA-N 0.000 description 1
- 102100025597 Caspase-4 Human genes 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010011091 Coronary artery thrombosis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 101100273284 Homo sapiens CASP4 gene Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- 229910010084 LiAlH4 Inorganic materials 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 238000011785 NMRI mouse Methods 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- IXUZXIMQZIMPSQ-ZBRNBAAYSA-N [(4s)-4-amino-4-carboxybutyl]azanium;(2s)-2-amino-4-hydroxy-4-oxobutanoate Chemical compound OC(=O)[C@@H](N)CCC[NH3+].[O-]C(=O)[C@@H](N)CC(O)=O IXUZXIMQZIMPSQ-ZBRNBAAYSA-N 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000002528 coronary thrombosis Diseases 0.000 description 1
- FJBFPHVGVWTDIP-UHFFFAOYSA-N dibromomethane Chemical compound BrCBr FJBFPHVGVWTDIP-UHFFFAOYSA-N 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 229960002768 dipyridamole Drugs 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2442158 | 1974-09-03 | ||
| DE2442158A DE2442158C3 (de) | 1974-09-03 | 1974-09-03 | Neue substituierte N- [1(3,4-Methylendioxyphenyl) propyl (2)] -N'-subst Phenylpiperazine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI752288A FI752288A (xx) | 1976-03-04 |
| FI60006B FI60006B (fi) | 1981-07-31 |
| FI60006C true FI60006C (fi) | 1981-11-10 |
Family
ID=5924765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI752288A FI60006C (fi) | 1974-09-03 | 1975-08-13 | Foerfarande foer framstaellning av farmakologiskt vaerdefulla n-(1-(3,4-metylendioxifenyl)propyl(2))-n'-(substituerad fenyl)piperaziner och deras syraadditionssalter |
Country Status (27)
| Country | Link |
|---|---|
| JP (1) | JPS52287A (xx) |
| AT (1) | AT344699B (xx) |
| BE (2) | BE833002A (xx) |
| BG (1) | BG26381A3 (xx) |
| CA (2) | CA1063027A (xx) |
| CH (1) | CH615174A5 (xx) |
| CS (1) | CS192521B2 (xx) |
| DD (1) | DD124118A5 (xx) |
| DE (1) | DE2442158C3 (xx) |
| DK (1) | DK137387C (xx) |
| ES (5) | ES440630A1 (xx) |
| FI (1) | FI60006C (xx) |
| FR (1) | FR2283682A1 (xx) |
| GB (3) | GB1521052A (xx) |
| HU (1) | HU176754B (xx) |
| IE (2) | IE43338B1 (xx) |
| IL (2) | IL48036A (xx) |
| LU (2) | LU73317A1 (xx) |
| NL (1) | NL7510319A (xx) |
| NO (1) | NO142911C (xx) |
| NZ (1) | NZ178566A (xx) |
| PH (1) | PH13631A (xx) |
| PL (1) | PL95233B1 (xx) |
| RO (1) | RO68380B (xx) |
| SE (1) | SE419084B (xx) |
| YU (1) | YU37164B (xx) |
| ZA (2) | ZA755601B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54109307U (xx) * | 1978-01-19 | 1979-08-01 | ||
| US4647606A (en) * | 1982-12-27 | 1987-03-03 | Owens-Corning Fiberglas Corporation | Blend of rapid set asphaltic emulsion with slow set asphalt emulsion |
| HU187229B (en) * | 1983-04-14 | 1985-11-28 | Koezponti Valto Hitelbank | Method for producing fodder increasing yield or additional fodder composition |
| AUPN359095A0 (en) * | 1995-06-19 | 1995-07-13 | Mount Shamrock Pty Ltd | Saw system |
-
1974
- 1974-09-03 DE DE2442158A patent/DE2442158C3/de not_active Expired
-
1975
- 1975-08-13 FI FI752288A patent/FI60006C/fi not_active IP Right Cessation
- 1975-08-25 AT AT653875A patent/AT344699B/de not_active IP Right Cessation
- 1975-08-28 RO RO83281A patent/RO68380B/ro unknown
- 1975-09-01 BG BG7530900A patent/BG26381A3/xx unknown
- 1975-09-01 DD DD188118A patent/DD124118A5/xx unknown
- 1975-09-01 CS CS755930A patent/CS192521B2/cs unknown
- 1975-09-02 IL IL48036A patent/IL48036A/xx unknown
- 1975-09-02 BE BE159686A patent/BE833002A/xx not_active IP Right Cessation
- 1975-09-02 JP JP50106441A patent/JPS52287A/ja active Pending
- 1975-09-02 GB GB3218/78A patent/GB1521052A/en not_active Expired
- 1975-09-02 ES ES440630A patent/ES440630A1/es not_active Expired
- 1975-09-02 BE BE159687A patent/BE833003A/xx not_active IP Right Cessation
- 1975-09-02 NO NO753020A patent/NO142911C/no unknown
- 1975-09-02 HU HU75BO1570A patent/HU176754B/hu unknown
- 1975-09-02 IL IL48033A patent/IL48033A/xx unknown
- 1975-09-02 GB GB36147/75A patent/GB1521051A/en not_active Expired
- 1975-09-02 YU YU2219/75A patent/YU37164B/xx unknown
- 1975-09-02 PL PL1975183066A patent/PL95233B1/pl unknown
- 1975-09-02 DK DK393775A patent/DK137387C/da active
- 1975-09-02 NL NL7510319A patent/NL7510319A/xx not_active Application Discontinuation
- 1975-09-02 SE SE7509746A patent/SE419084B/xx unknown
- 1975-09-02 GB GB36152/75A patent/GB1514546A/en not_active Expired
- 1975-09-03 CA CA234,708A patent/CA1063027A/en not_active Expired
- 1975-09-03 IE IE1930/75A patent/IE43338B1/en unknown
- 1975-09-03 CA CA234,707A patent/CA1061343A/en not_active Expired
- 1975-09-03 FR FR7527056A patent/FR2283682A1/fr active Granted
- 1975-09-03 LU LU73317A patent/LU73317A1/xx unknown
- 1975-09-03 PH PH17540A patent/PH13631A/en unknown
- 1975-09-03 ZA ZA755601A patent/ZA755601B/xx unknown
- 1975-09-03 ZA ZA755602A patent/ZA755602B/xx unknown
- 1975-09-03 IE IE1929/75A patent/IE41667B1/en unknown
- 1975-09-03 NZ NZ178566A patent/NZ178566A/xx unknown
- 1975-09-03 LU LU73316A patent/LU73316A1/xx unknown
-
1976
- 1976-12-03 ES ES453932A patent/ES453932A1/es not_active Expired
- 1976-12-03 ES ES453935A patent/ES453935A1/es not_active Expired
- 1976-12-03 ES ES453934A patent/ES453934A1/es not_active Expired
- 1976-12-03 ES ES453933A patent/ES453933A1/es not_active Expired
-
1979
- 1979-05-07 CH CH425779A patent/CH615174A5/de not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20080280941A1 (en) | 8-Phenoxy-Gamma Carboline Derivatives | |
| DK168535B1 (da) | 2,6-Dialkylphenylaminocarbonylmethyl-piperazinderivater, fremgangsmåde til fremstilling deraf, samt farmaceutisk præparat indeholdende disse derivater | |
| EP1948607B1 (en) | Cyclopropyl amines as modulators of the histamine h3 receptor | |
| IE914218A1 (en) | Novel 4-arylpiperazines and 4-arylpiperidines | |
| AU588757B2 (en) | Phenylisopropyl omine derivative | |
| JP2008526706A (ja) | ニトロ置換フェニル−ピペラジン化合物、それらの調製及び薬剤におけるそれらの使用 | |
| FI60006C (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla n-(1-(3,4-metylendioxifenyl)propyl(2))-n'-(substituerad fenyl)piperaziner och deras syraadditionssalter | |
| IE53827B1 (en) | Amine derivatives, processes for their production and pharmaceutical compositions containing them | |
| FI80448C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara piperazinkarboxamidderivat. | |
| DK157864B (da) | Hidtil ukendte 1-piperazincarboxamidderivater substitueret paa det basiske nitrogenatom samt farmaceutiske praeparater og sammensaetninger indeholdende disse | |
| PL125663B1 (en) | Process for preparing novel derivatives of n-(trimethoxybenzyl)-piperazine | |
| EP0042366B1 (en) | Diphenylbutyl-1-acylpiperazines | |
| PL163028B1 (pl) | Sposób wytwarzania nowych pochodnych aminopropanolu PL PL PL | |
| EP0080992B1 (en) | 1-piperazinocarboxylates, process for their preparation and pharmaceutical compositions containing them | |
| US2870152A (en) | Unilcu | |
| CS196399B2 (en) | Process for preparing 2-substituted 1-/omega-amino-alkoxy/-benzenes | |
| JPS606349B2 (ja) | ２―（ω‐アミノアルコキシ）ジフエニルメタン類 | |
| TERA et al. | Agents for the Treatment of Overactive Detrusor. VIII. 1 “’ | |
| EP1288208B1 (en) | Process for the preparation of 2-(4-Alkyl-1-Piperazinyl)-Benzaldehyde and -Benzylidenyl compounds by Nucleophilc Aromatic Substitution of 2-Fluorobenzaldehyde with 4-Alkyl-1-Piperazine in Water as Solvent | |
| TANIGUCHI et al. | Agents for the Treatment of Overactive Detrusor. VIII. Synthesis and Pharmacological Properties of 4, 4-Diphenyl-2-cycloalkenylamines Including FK584 and 3, 3-or 4, 4-Diphenylcycloalkylamines | |
| US5162324A (en) | Naphyl piperazines useful as 5-HT1A receptor ligands | |
| FI66365C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,4-cykloalkano-oxazepiner vari oxazepinringen och cykloalkanogruppen aer i cis-staellningen i foerhaollande till varandra | |
| Glushkov et al. | Synthesis and biological activity of hydroxyphencyclidine homologs | |
| Jílek et al. | 1-(3-Dimethylamino-1-phenylpropyl) piperazines and related compounds: Synthesis and pharmacological screening | |
| FI84265B (fi) | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 1-alkyl-2-alkoximetyl-3-alkynyloxipiperidin- och -azepinderivat. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: C.H. BOEHRINGER SOHN |